Advanced search

Authors whose works are in public domain in at least one jurisdiction

List of works by David Belada

1-50 of 59 results

View this query on the Wikidata Query Service
Rituximab maintenance for 2 years in patients with high tumour burden follicular lymphoma responding to rituximab plus chemotherapy (PRIMA): a phase 3, randomised controlled trial.

scientific article
Obinutuzumab or Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Previously Untreated Diffuse Large B-Cell Lymphoma.

scientific article
Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a global, double-blind, randomised, phase 3 trial

scientific article published on 04 December 2018
Lenalidomide versus investigator's choice in relapsed or refractory mantle cell lymphoma (MCL-002; SPRINT): a phase 2, randomised, multicentre trial

scientific article
Randomized Phase III Trial of Ibrutinib and Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Non-Germinal Center B-Cell Diffuse Large B-Cell Lymphoma.

scientific article
Dulanermin with rituximab in patients with relapsed indolent B-cell lymphoma: an open-label phase 1b/2 randomised study

scientific article published on 25 March 2015
Pre-transplant positron emission tomography in patients with relapsed Hodgkin lymphoma

scientific article published on 23 June 2011
Prognostic value of end-of-induction PET response after first-line immunochemotherapy for follicular lymphoma (GALLIUM): secondary analysis of a randomised, phase 3 trial

article
A simplified scoring system in de novo follicular lymphoma treated initially with immunochemotherapy.

scientific article published on 17 April 2018
Rituximab in combination with high-dose dexamethasone for the treatment of relapsed/refractory chronic lymphocytic leukemia.

scientific article
Retrospective analysis of 235 unselected patients with mantle cell lymphoma confirms prognostic relevance of Mantle Cell Lymphoma International Prognostic Index and Ki-67 in the era of rituximab: long-term data from the Czech Lymphoma Project Databa

scientific article
A new prognostic score for elderly patients with diffuse large B-cell lymphoma treated with R-CHOP: the prognostic role of blood monocyte and lymphocyte counts is absent

scientific article
Dacetuzumab plus rituximab, ifosfamide, carboplatin and etoposide as salvage therapy for patients with diffuse large B-cell lymphoma relapsing after rituximab, cyclophosphamide, doxorubicin, vincristine and prednisolone: a randomized, double-blind,

scientific article published on 26 February 2015
Role of rituximab in treatment of patients with primary central nervous system lymphoma: a retrospective analysis of the Czech lymphoma study group registry

scientific article published on 18 April 2016
Sustained Progression-Free Survival Benefit of Rituximab Maintenance in Patients With Follicular Lymphoma: Long-Term Results of the PRIMA Study

scientific article published on 24 July 2019
Venous thromboembolism in patients with chronic lymphocytic leukemia.

scientific article
Radiotherapy with rituximab may be better than radiotherapy alone in first-line treatment of early-stage follicular lymphoma: is it time to change the standard strategy?

scientific article
Pixantrone-rituximab versus gemcitabine-rituximab in relapsed/refractory aggressive non-Hodgkin lymphoma

scientific article published on 20 April 2016
Alternating R-CHOP and R-cytarabine is a safe and effective regimen for transplant-ineligible patients with a newly diagnosed mantle cell lymphoma.

scientific article
Potential loss of prognostic significance of minimal residual disease assessment after R-CHOP-based induction in elderly patients with mantle cell lymphoma in the era of rituximab maintenance

scientific article published on 13 September 2018
Impact of rituximab maintenance and maintenance schedule on prognosis in first-line treatment of follicular lymphoma. Retrospective analysis from Czech Lymphoma Study Group (CLSG) database.

scientific article published on 21 August 2015
Trimodality imaging of colonic lymphoma.

scientific article
Diffuse large B-cell lymphoma in a patient with hyper-IgE syndrome: Successful treatment with risk-adapted rituximab-based immunochemotherapy

scientific article published on 11 March 2010
NK/T-cell lymphoma nasal type with an unusual clinical course

scientific article published on 01 November 2014
Experiences in the treatment of refractory chylothorax associated with lymphoproliferative disorders

scientific article published on 09 January 2019
The incidence of biopsy-proven transformation in follicular lymphoma in the rituximab era. A retrospective analysis from the Czech Lymphoma Study Group (CLSG) database

scientific article published on 9 January 2018
Five years of experience with rituximab plus high-dose dexamethasone for relapsed/refractory chronic lymphocytic leukemia

scientific article published on 8 December 2015
The use of formalin-fixed, paraffin-embedded lymph node samples for the detection of minimal residual disease in mantle cell lymphoma

scientific article published on 14 October 2014
Statin use is safe and does not impact prognosis in patient with de novo follicular lymphoma treated with immunochemotherapy: An exploratory analysis of the PRIMA cohort study.

scientific article
Prospective subgroup analyses of the randomized MCL-002 (SPRINT) study: lenalidomide versus investigator's choice in relapsed or refractory mantle cell lymphoma.

scientific article published on 28 November 2017
Optimization of the therapeutic procedure during LDL-apheresis--a computerized model

scientific article published in April 2005
A RANDOMIZED PHASE 3 TRIAL OF ZANUBRUTINIB VERSUS IBRUTINIB IN SYMPTOMATIC WALDENSTRÖM MACROGLOBULINEMIA:THE ASPEN STUDY

scientific article published on 30 July 2020
First-line therapy for T cell lymphomas: a retrospective population-based analysis of 906 T cell lymphoma patients

scientific article published on 08 May 2019
Plasma levels of basic fibroblast growth factor and vascular endothelial growth factor and their association with IgVH mutation status in patients with B-cell chronic lymphocytic leukemia

scientific article published on 01 October 2006
Peripheral T-cell lymphoma, unspecified--the analysis of the data from the Czech Lymphoma Study Group (CLSG) registry.

scientific article
Addition of rituximab significantly improves outcomes in patients with diffuse large B-cell lymphoma--a single-center, retrospective study

scientific article published in January 2007
Cutaneous natural killer (NK) / T-cell lymphoma: nasal type with extensive facial destruction

scientific article published in December 2009
Maintenance rituximab in newly diagnosed mantle cell lymphoma patients: a real world analysis from the Czech lymphoma study group registry

scientific article published on 06 September 2018
Intravascular large B-cell lymphoma presenting as cutaneous panniculitis

scientific article published on 01 January 2003
Primary testicular lymphoma

scientific article published in January 2017
Ten years' experience with four cycles of bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, prednisone, procarbazine (BEACOPP)-escalated followed by four cycles of baseline-dose BEACOPP in patients with advanced stage Hodgkin lymphom

scientific article published on 10 February 2015
RCD Chemoimmunotherapy For Relapsed Chronic Lymphocytic Leukaemia

scientific article published on 06 October 2020
Severe anemia caused by combination of autoimmune hemolysis, pure red cell aplasia and massive bone marrow infiltration in an elderly patient with chronic lymphocytic leukemia: successful treatment with rituximab

scientific article published on 6 January 2010
Případy z klinické praxe: zkušenosti s léčbou idelalisibem (Zydelig®) u pacientů s CLL

book edition published in 2016
Phase 2 study of parsaclisib (INCB050465), a highly selective, next-generation PI3Kδ inhibitor, in relapsed or refractory diffuse large B-cell lymphoma (CITADEL-202)

scientific article published on 03 November 2020
Tumorous neo-vascularization: a newly recognized endoscopic feature of intestinal non-Hodgkin lymphoma

scientific article published on 01 February 2007
Emergence of a lymphoma imitating an infectious infiltration surrounding the infrarenal aorta after EVAR

scientific article published on 04 July 2019
Diagnostické a léčebné postupy u nemocných s maligními lymfomy

book edition published in 2023
Treatment of Relapsed/Refractory Hodgkin Lymphoma: Real-World Data from the Czech Republic and Slovakia

scientific article published on 28 August 2019
Pixantrone plus rituximab versus gemcitabine plus rituximab in patients with relapsed aggressive B-cell non-Hodgkin lymphoma not eligible for stem cell transplantation: a phase 3, randomized, multicentre trial (PIX306)

scientific article published on 27 December 2019

Paulina is supported by:

About Paulina

Help